Go Therapeutics, Inc. — Form D
Go Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-16. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-08-16
- Form: D
- Accession: 0001714218-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 1
- Date of first sale: 2017-08-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-292903
Issuer
- Name: Go Therapeutics, Inc.
- CIK: 0001714218
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: ONE BROADWAY, CAMBRIDGE, MA, 02142
- Phone: 617-816-4637
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Gregory L Chase | Director | Cambridge, MA |
| Constantine Theodoropulos | Director | Cambridge, MA |
| Thayer L White | Director | Cambridge, MA |
| Constantine Theodoropulos | Executive Officer | Cambridge, MA |
More